Due to the pro-metastatic effects of EGFR signals in cancer cells, other than the cytotoxicity induced by Gefitinib, the function of SCD1 in the ability to migrate and invade A549 (Fig. 3a–c) and H1573 cell lines (Fig. 3d–f) was estimated. Here, EGFR is linked to cancer.